Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Gynecol Oncol ; 144(1): 187-192, 2017 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-27839789

RESUMO

INTRODUCTION: Minimally invasive surgery (MIS) has been associated with diminished postoperative pain and analgesia requirements. The objective of the current study was to evaluate the use of analgesia in the post-operative period following robotic surgery for endometrial cancer. METHODS: All consecutive patients who underwent robotic surgery for the treatment of endometrial cancer were included in this study. The timing, dose, and type of analgesics administered postoperatively were recorded from patients' electronic medical record. Data was compared to a matched historical cohort of patients who underwent laparotomy before the introduction of the robotic program. RESULTS: Only eight patients (2.4%, 5 during the first 25 cases and 3 following mini-laparotomy) received patient-controlled analgesia (PCA) following robotic surgery. Most patients' pain was alleviated by over-the-counter analgesics (acetaminophen, non-steroidal anti-inflammatories). In comparison to laparotomy, patients who underwent robotic surgery required significantly less opioids (71mg vs. 12mg IV morphine, p<0.0001) and non-opioids (4810mg vs. 2151mg acetaminophen, 1892 vs. 377mg ibuprofen, and 1470mg vs. 393mg naproxen; all p<0.0001). CONCLUSION: Patients require less analgesics (opioids and non-opioids) following robotic surgery in comparison to conventional laparotomy, including the elderly and the obese. The diminished pain medication use is associated with some cost savings.


Assuntos
Analgésicos/administração & dosagem , Neoplasias do Endométrio/cirurgia , Dor Pós-Operatória/tratamento farmacológico , Procedimentos Cirúrgicos Robóticos/efeitos adversos , Acetaminofen/administração & dosagem , Idoso , Analgesia Controlada pelo Paciente/economia , Analgésicos/economia , Anti-Inflamatórios não Esteroides/administração & dosagem , Custos de Medicamentos , Registros Eletrônicos de Saúde , Feminino , Humanos , Ibuprofeno/administração & dosagem , Pessoa de Meia-Idade , Procedimentos Cirúrgicos Minimamente Invasivos/efeitos adversos , Morfina/administração & dosagem , Naproxeno/administração & dosagem , Estudos Retrospectivos
2.
Polymers (Basel) ; 10(5)2018 May 21.
Artigo em Inglês | MEDLINE | ID: mdl-30966589

RESUMO

Despite the rapid and great developments in the field of 3D hydrogel printing, a major ongoing challenge is represented by the development of new processable materials that can be effectively used for bioink formulation. In this work, we present an approach to 3D deposit, a new class of fully-synthetic, biocompatible PolyIsoCyanide (PIC) hydrogels that exhibit a reverse gelation temperature close to physiological conditions (37 °C). Being fully-synthetic, PIC hydrogels are particularly attractive for tissue engineering, as their properties-such as hydrogel stiffness, polymer solubility, and gelation kinetics-can be precisely tailored according to process requirements. Here, for the first time, we demonstrate the feasibility of both 3D printing PIC hydrogels and of creating dual PIC-Gelatin MethAcrylate (GelMA) hydrogel systems. Furthermore, we propose the use of PIC as fugitive hydrogel to template structures within GelMA hydrogels. The presented approach represents a robust and valid alternative to other commercial thermosensitive systems-such as those based on Pluronic F127-for the fabrication of 3D hydrogels through additive manufacturing technologies to be used as advanced platforms in tissue engineering.

SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa